Patent · US Active

Combination therapy for treating proliferative diseases

US9006284B2 · kind B2 · utility

3Cited by

10References

11Claims

0Family size

Assignee

Bionomics Limited · AU

Inventors

Gabriel Kremmidiotis · Loxton, AU
David Bibby · Emeryville, US
Annabell Francis Leske · Adelaide, AU

Key dates

Filing date	Aug 25, 2010
Grant date	Apr 14, 2015
Priority date	—
Expiry date	Aug 25, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A pharmaceutical composition of a tubulin polymerisation inhibitor and an mTOR inhibitor and a method of treating proliferative disease with a combination of a tubulin polymerisation inhibitor and an mTOR inhibitor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.